Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Monoclonal antibody as therapy for malignant lymphomas.

Literature DB >> 16644494

Monoclonal antibody as therapy for malignant lymphomas.

Abstract

Rituximab was the first monoclonal antibody to have been registered for the treatment of B-cell lymphomas. Randomized studies have demonstrated its activity in follicular lymphoma, mantle-cell lymphoma, and diffuse large B-cell lymphoma in untreated or relapsing patients. Because of its high activity and low toxicity ratio, rituximab has transformed the outcome of patients with B-cell lymphoma. A combination of rituximab plus chemotherapy, R-CHOP, has the highest efficacy ever described with any chemotherapy in diffuse large B-cell lymphoma and follicular lymphoma. The role of radio-labelled antibodies is still to be defined.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2006 PMID： 16644494 DOI： 10.1016/j.crvi.2005.12.006

Source DB: PubMed Journal: C R Biol ISSN： 1631-0691 Impact factor: 1.583

Keyword Cloud
Cited

12 in total

1. Primary pancreatic follicle center-derived lymphoma masquerading as carcinoma.

Authors: Riley E Alexander; Attila Nakeeb; Kumar Sandrasegaran; Michael J Robertson; Caroline An; Mohammad A Al-Haddad; Jey-Hsin Chen
Journal: Gastroenterol Hepatol (N Y) Date: 2011-12

2. Primary pancreatic lymphoma in Korea--a single center experience.

Authors: Won Jae Yoon; Yong Bum Yoon; Youn Joo Kim; Ji Kon Ryu; Yong-Tae Kim
Journal: J Korean Med Sci Date: 2010-03-19 Impact factor: 2.153

Review 3. Solid pancreatic masses: not always adenocarcinoma.

Authors: Tegpal Atwal; Ferga C Gleeson
Journal: Gastroenterol Hepatol (N Y) Date: 2012-12

4. Acute kidney injury secondary to renal large B-cell lymphoma: role of early renal biopsy.

Authors: Suhail Al-Salam; Ahmad Shaaban; Maha Alketbi; Naveed U Haq; Samra Abouchacra
Journal: Int Urol Nephrol Date: 2010-03-31 Impact factor: 2.370

Review 5. The role of transplantation in diffuse large B-cell lymphoma: the impact of rituximab plus chemotherapy in first-line and relapsed settings.

Authors: Celso Arrais Rodrigues; Poliana Alves Patah; Yana A S Novis; Chitra Hosing; Marcos de Lima
Journal: Curr Hematol Malig Rep Date: 2011-03 Impact factor: 3.952

Monoclonal antibody as therapy for malignant lymphomas.

1. Primary pancreatic follicle center-derived lymphoma masquerading as carcinoma.

2. Primary pancreatic lymphoma in Korea--a single center experience.

Review 3. Solid pancreatic masses: not always adenocarcinoma.

4. Acute kidney injury secondary to renal large B-cell lymphoma: role of early renal biopsy.

Review 5. The role of transplantation in diffuse large B-cell lymphoma: the impact of rituximab plus chemotherapy in first-line and relapsed settings.

Review 6. Role of microRNAs on therapy resistance in Non-Hodgkin's lymphoma.

Review 7. Contribution of Dysregulated B-Cells and IgE Antibody Responses to Multiple Sclerosis.

Review 8. B-cell Therapy for Multiple Sclerosis: Entering an era.

9. The frequency and clinical relevance of multidrug resistance protein expression in patients with lymphoma.

10. WBSMDA: Within and Between Score for MiRNA-Disease Association prediction.